Tuesday, January 05, 2021 10:54:04 AM
Question on DRIOW?!?
I purchased DRIOW last week at $0.43 average share price. I won 41808 shares at this average.
When I reached out to IR they said that the effective share price is $86.60 due to the 20 to 1 Reverse split in November of 2019.
I'd like to understand if I should cut my losses (made a mistake did not do my DD and thought this was common stock and not Warrants) and sell now or if this will work in my favor?
Thanks for the help!
I purchased DRIOW last week at $0.43 average share price. I won 41808 shares at this average.
When I reached out to IR they said that the effective share price is $86.60 due to the 20 to 1 Reverse split in November of 2019.
I'd like to understand if I should cut my losses (made a mistake did not do my DD and thought this was common stock and not Warrants) and sell now or if this will work in my favor?
Thanks for the help!
Recent DRIO News
- DarioHealth Reports First Quarter 2026 Financial and Operating Results • PR Newswire (US) • 05/13/2026 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 10:05:57 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/07/2026 08:05:07 PM
- DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026 • PR Newswire (US) • 05/04/2026 12:30:00 PM
- Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative Research • PR Newswire (US) • 04/20/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 12:21:08 PM
- Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling • PR Newswire (US) • 04/13/2026 12:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/30/2026 10:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/30/2026 04:15:17 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/19/2026 09:03:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/19/2026 09:02:06 PM
- DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results • PR Newswire (US) • 03/19/2026 10:30:00 AM
- DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026 • PR Newswire (US) • 03/11/2026 12:30:00 PM
- Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health • PR Newswire (US) • 03/10/2026 12:00:00 PM
- Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management • PR Newswire (US) • 03/03/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 09:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2026 09:06:11 PM
- Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms • PR Newswire (US) • 01/21/2026 01:00:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/29/2025 09:05:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/22/2025 09:12:29 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 12/16/2025 10:08:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/11/2025 10:15:51 PM
